1. Home
  2. FLIC vs DBVT Comparison

FLIC vs DBVT Comparison

Compare FLIC & DBVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FLIC
  • DBVT
  • Stock Information
  • Founded
  • FLIC 1927
  • DBVT 2002
  • Country
  • FLIC United States
  • DBVT France
  • Employees
  • FLIC N/A
  • DBVT N/A
  • Industry
  • FLIC Major Banks
  • DBVT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • FLIC Finance
  • DBVT Health Care
  • Exchange
  • FLIC Nasdaq
  • DBVT Nasdaq
  • Market Cap
  • FLIC 280.5M
  • DBVT 239.9M
  • IPO Year
  • FLIC N/A
  • DBVT N/A
  • Fundamental
  • Price
  • FLIC N/A
  • DBVT $7.99
  • Analyst Decision
  • FLIC Buy
  • DBVT Buy
  • Analyst Count
  • FLIC 1
  • DBVT 4
  • Target Price
  • FLIC $16.56
  • DBVT $14.81
  • AVG Volume (30 Days)
  • FLIC 67.6K
  • DBVT 95.6K
  • Earning Date
  • FLIC 07-24-2025
  • DBVT 07-29-2025
  • Dividend Yield
  • FLIC 7.08%
  • DBVT N/A
  • EPS Growth
  • FLIC N/A
  • DBVT N/A
  • EPS
  • FLIC 0.72
  • DBVT N/A
  • Revenue
  • FLIC $85,364,000.00
  • DBVT $3,497,000.00
  • Revenue This Year
  • FLIC $17.38
  • DBVT $1,700.53
  • Revenue Next Year
  • FLIC N/A
  • DBVT $535.67
  • P/E Ratio
  • FLIC $16.49
  • DBVT N/A
  • Revenue Growth
  • FLIC N/A
  • DBVT N/A
  • 52 Week Low
  • FLIC $9.30
  • DBVT $2.21
  • 52 Week High
  • FLIC $15.03
  • DBVT $12.78
  • Technical
  • Relative Strength Index (RSI)
  • FLIC 7.12
  • DBVT 37.51
  • Support Level
  • FLIC $11.68
  • DBVT $8.33
  • Resistance Level
  • FLIC $12.20
  • DBVT $9.92
  • Average True Range (ATR)
  • FLIC 0.23
  • DBVT 0.85
  • MACD
  • FLIC -0.82
  • DBVT -0.38
  • Stochastic Oscillator
  • FLIC 0.00
  • DBVT 0.29

About FLIC First of Long Island Corporation (The)

First of Long Island Corp is a holding company that provides financial services. It offers services of saving accounts, current accounts, and capital gain accounts. The company also provides lending services, such as commercial and residential mortgage loans, industrial loans, small business credit scored loans, and other credit facilities. In addition, the company provides account reconciliation services, ATM Banking, bill payment, cash management services, mobile banking, online banking, and payroll services to privately owned businesses, professionals, consumers, and public bodies.

About DBVT DBV Technologies S.A.

DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Its main product candidate under development is Viaskin Peanut for the treatment of peanut-allergic patients. In addition, the company also has earlier-stage food allergy programs, including Viaskin Milk and Eosinophilic Esophagitis, or EoE.

Share on Social Networks: